Search bioRxivSearch

bioRxiv · 10.1101/761189

A Computational Framework to Study the Primary Lifecycle Metabolism of Arabidopsis thaliana

Abstract

Stoichiometric Models of metabolism have proven valuable tools for increased understanding of metabolism and accuracy of synthetic biology interventions to achieve desirable phenotypes. Such models have been used in conjunction with optimization-based and have provided \"snapshot\" views of organism metabolism at specific stages of growth, generally at exponential growth. This approach has limitations in that metabolic history of the modeled system cannot be studied. The inability to study the complete metabolic history has limited stoichiometric metabolic modeling only to the static investigations of an inherently dynamic process. In this work, we have sought to address this limitation by introducing an optimization-based computational framework and applying to a stoichiometric model of the model plant Arabidopsis thaliana of four linked sub-models of leaf, root, seed, and stem tissues which models the core carbon metabolism through the lifecycle of arabidopsis (named as p-ath780). Uniquely, this framework and model considers diurnal metabolism, changes in tissue mass, carbohydrate storage, and loss of plant mass to senescence and seed dispersal. p-ath780 provide \"snapshots\" of core-carbon metabolism at one hour intervals of growth, in order to show the evolution of metabolism and whole-plant growth across the lifecycle of a single representative plant. Further, it can simulate important growth stages including seed germination, leaf development, flower production, and silique ripening. The computational framework has shown broad agreement with published experimental data in tissue mass yield, maintenance cost, senescence cost, and whole-plant growth checkpoints. Having focused on core-carbon metabolism, it serves as a scaffold for lifecycle models of other plant systems, to further increase the sophistication of in silico metabolic modeling, and to increase the range of hypotheses which can be investigated in silico. As an example, we have investigated the effect of alternate growth objectives on this plant over the lifecycle.\n\nAuthor SummaryIn an attempt to study the evolution of metabolism across the lifecycle of plants, in this work we have created an optimization-based framework for the in silico modeling of plant metabolism across the lifecycle of a model plant. We then applied this framework to four core-carbon tissue-level (namely, leaf, root, seed, and stem) stoichiometric models of the model plant species Arabidopsis thaliana, and further informed this framework with a wide array of published in vivo data to increase model and framework accuracy. Unique to the p-ath780 model, comparted to other models of plant metabolism, is the simultaneous considerations of diurnal metabolism, carbohydrate storage, changes in tissue mass (including losses), and changes in metabolism with respect to plant growth stage. This provides a more complete picture of plant metabolism and allows for a wider array of future studies of plant metabolism, particularly since we have only modeled the core carbon metabolism of A. thaliana, allowing this work to serve as a framework for studies of other plant systems.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Schroeder, W. L., Saha, R.. 2019-09-08. A Computational Framework to Study the Primary Lifecycle Metabolism of Arabidopsis thaliana. https://doi.org/10.1101/761189

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology